Authors:
Minkoff, H
Ahdieh, L
Massad, LS
Anastos, K
Watts, DH
Melnick, S
Muderspach, L
Burk, R
Palefsky, J
Citation: H. Minkoff et al., The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women, AIDS, 15(16), 2001, pp. 2157-2164
Authors:
Safra, T
Groshen, S
Jeffers, S
Tsao-Wei, DD
Zhou, LY
Muderspach, L
Roman, L
Morrow, CP
Burnett, A
Muggia, FM
Citation: T. Safra et al., Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome, CANC CYTOP, 91(1), 2001, pp. 90-100
Authors:
Safra, T
Groshen, S
Jeffers, S
Tsao-Wei, DD
Zhou, LY
Muderspach, L
Roman, L
Morrow, CP
Burnett, A
Muggia, FM
Citation: T. Safra et al., Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome, CANCER, 91(1), 2001, pp. 90-100
Authors:
Harlow, SD
Schuman, P
Cohen, M
Ohmit, SE
Cu-Uvin, S
Lin, XH
Anastos, K
Burns, D
Greenblatt, R
Minkoff, H
Muderspach, L
Rompalo, A
Warren, D
Young, MA
Klein, RS
Citation: Sd. Harlow et al., Effect of HIV infection on menstrual cycle length, J ACQ IMM D, 24(1), 2000, pp. 68-75
Authors:
Muderspach, L
Wilczynski, S
Roman, L
Bade, L
Felix, J
Small, LA
Kast, WM
Fascio, G
Marty, V
Weber, J
Citation: L. Muderspach et al., A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive, CLIN CANC R, 6(9), 2000, pp. 3406-3416